JFL LIFE SCIENCES LIMITED Share Price

JFL Life Sciences Limited is an India-based pharmaceutical company. The Company's business segment comprises manufacturing and selling of pharmaceutical products. It is engaged in domestic as well as international business. The Company's main product categories include Dry powder injections, Tablets & Capsules (B-Lactam) solid oral dosage form, Tablet, and capsules (General) and Oral Rehydration Solutions (ORS). Its beta-lactam dry powder injection products include Ampicillin Injection, Cefotaxime Sodium Injection, Cefazoline Sodium Injection, meropenem injection, amoxicillin injection, cefTAZidime injection, flucloxacillin injection, among others. Its beta-lactam tablets and capsule products include Cefadroxil Tablets, Cefadroxil Capsules, among others. Its general tablet and capsule products include Azithromycin Tablets, Iburofen Tablets, Ciprofloxacin Tablets, Ofloxacin Tablets, Paracetamol Tablets, among others. These products are offered in different milligrams (mg).As of 14 Jun 2026, JFL LIFE SCIENCES LIMITED share price is ₹9.45. The stock opened at ₹9.45, compared to its previous close of ₹9.45. During today's trading session, JFL LIFE SCIENCES LIMITED share price moved in the range of ₹9.45 to ₹9.45, with an average price of ₹9.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹9.45 and a high of ₹9.45.

The market capitalization of JFL LIFE SCIENCES LIMITED is ₹62 Crs, with a P/E ratio of 9.7 and a dividend yield of 0.00%.